688613 奥精医疗
已收盘 08-14 15:00:01
资讯
新帖
简况
医疗耗材上市公司董秘PK:30岁及以下的董秘占比5% 采纳股份陆维炜为最年轻男董秘
新浪证券 · 08-08
医疗耗材上市公司董秘PK:30岁及以下的董秘占比5% 采纳股份陆维炜为最年轻男董秘
骨科材料概念盘中跳水,正海生物跌1.24%
市场透视 · 08-08
骨科材料概念盘中跳水,正海生物跌1.24%
奥精医疗获融资买入0.11亿元,近三日累计买入0.36亿元
金融界 · 08-02
奥精医疗获融资买入0.11亿元,近三日累计买入0.36亿元
骨科材料概念盘中拉升,冠昊生物涨2.45%
市场透视 · 07-23
骨科材料概念盘中拉升,冠昊生物涨2.45%
奥精医疗(688613.SH):OssaNova™人工骨修复材料在越南获得注册证
智通财经 · 07-21
奥精医疗(688613.SH):OssaNova™人工骨修复材料在越南获得注册证
医疗耗材概念盘中拉升,洁特生物涨4.19%
市场透视 · 07-21
医疗耗材概念盘中拉升,洁特生物涨4.19%
2025年中国口腔种植行业经营效益分析:集采大幅压缩行业利润空间
前瞻产业研究院 · 07-16
2025年中国口腔种植行业经营效益分析:集采大幅压缩行业利润空间
渤小海伴您读研报之奥精医疗
渤海证券财富管理 · 07-16
渤小海伴您读研报之奥精医疗
多家跨国医疗巨头奔赴链博会,本土药械供应链再升级
第一财经 · 07-15
多家跨国医疗巨头奔赴链博会,本土药械供应链再升级
每周股票复盘:奥精医疗(688613)股东大会审议通过募投项目调整议案
证券之星 · 07-12
每周股票复盘:奥精医疗(688613)股东大会审议通过募投项目调整议案
奥精医疗股价上涨1.78%,临时股东大会通过募投项目调整议案
金融界 · 07-11
奥精医疗股价上涨1.78%,临时股东大会通过募投项目调整议案
骨科材料概念盘中拉升,*ST荣控涨1.66%
市场透视 · 07-11
骨科材料概念盘中拉升,*ST荣控涨1.66%
骨科材料概念盘中跳水,奥精医疗跌0.45%
市场透视 · 07-10
骨科材料概念盘中跳水,奥精医疗跌0.45%
神经外科业务收入大幅下滑被问询,奥精医疗回复
南方财经网 · 07-07
神经外科业务收入大幅下滑被问询,奥精医疗回复
奥精医疗一季度核心产品出货量增长174%
财经网 · 07-06
奥精医疗一季度核心产品出货量增长174%
每周股票复盘:奥精医疗(688613)子公司获医疗器械生产许可证及募投项目调整
证券之星 · 07-05
每周股票复盘:奥精医疗(688613)子公司获医疗器械生产许可证及募投项目调整
公告解读
投资快报 · 07-01
公告解读
奥精医疗放量突破创5日新高 估值高压触发资金博弈加剧
智选洞察 · 06-30
奥精医疗放量突破创5日新高 估值高压触发资金博弈加剧
医疗耗材概念盘中拉升,奥精医疗涨3.90%
市场透视 · 06-30
医疗耗材概念盘中拉升,奥精医疗涨3.90%
每周股票复盘:奥精医疗(688613)调整募投项目及召开临时股东大会
证券之星 · 06-28
每周股票复盘:奥精医疗(688613)调整募投项目及召开临时股东大会
加载更多
公司概况
公司名称:
奥精医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-05-21
主营业务:
奥精医疗科技股份有限公司的主营业务是高端生物医用材料及相关医疗器械产品的研发、生产、销售及服务。公司的主要产品是BONGOLD、单牙抗旋基台、骼金、齿贝、颅瑞、口腔种植体。报告期内,公司除获批设立博士后科研工作站,还被列入2024年北京市国际科技创新中心知识产权能力提升计划项目拟支持单位名单。
发行价格:
16.43
{"stockData":{"symbol":"688613","market":"SH","secType":"STK","nameCN":"奥精医疗","latestPrice":20.27,"timestamp":1755154801000,"preClose":21.04,"halted":0,"volume":5060007,"delay":0,"changeRate":-0.0366,"floatShares":137000000,"shares":137000000,"eps":-0.1355,"marketStatus":"已收盘","change":-0.77,"latestTime":"08-14 15:00:01","open":21.03,"high":21.17,"low":20.16,"amount":103000000,"amplitude":0.048,"askPrice":20.3,"askSize":1,"bidPrice":20.27,"bidSize":227,"shortable":0,"etf":0,"ttmEps":-0.1355,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1755221400000},"marketStatusCode":5,"adr":0,"adjPreClose":21.04,"symbolType":"stock_kcb","openAndCloseTimeList":[[1755135000000,1755142200000],[1755147600000,1755154800000]],"highLimit":23.14,"lowLimit":18.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":137008584,"isCdr":false,"pbRate":1.97,"roa":"--","roe":"0.07%","epsLYR":-0.09,"committee":0.434903,"marketValue":2777000000,"turnoverRate":0.0369,"status":1,"afterMarket":{"amount":0,"volume":0,"close":20.27,"buyVolume":0,"sellVolume":0,"time":1755156839260,"indexStatus":"已收盘 08-14 15:30:00","preClose":21.04},"floatMarketCap":2777000000},"requestUrl":"/m/hq/s/688613","defaultTab":"news","newsList":[{"id":"2557162955","title":"医疗耗材上市公司董秘PK:30岁及以下的董秘占比5% 采纳股份陆维炜为最年轻男董秘","url":"https://stock-news.laohu8.com/highlight/detail?id=2557162955","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557162955?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:33","pubTimestamp":1754620380,"startTime":"0","endTime":"0","summary":"新浪财经《2024年度A股董秘数据报告》显示,2024年A股上市公司董秘薪酬合计达40.86亿元,平均年薪75.43万元。从董秘的年龄分布来看,40岁-50岁董秘是市场的中坚力量,占比共计达到45%;50岁以上的董秘占比为14%;30岁-40岁的董秘群体占比为36%;30岁及以下董秘群体占比为5%。其中,目前仍任职的最年轻的男上市公司董秘年龄30岁,为采纳股份的陆维炜;最年轻的女董秘年龄为29岁,为华兰股份的刘雪。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808103341a47c22f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808103341a47c22f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688161","603309","688029","BK0251","159891","688351","301122","688613","688576"],"gpt_icon":0},{"id":"2557515972","title":"骨科材料概念盘中跳水,正海生物跌1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515972?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:46","pubTimestamp":1754617607,"startTime":"0","endTime":"0","summary":"08月08日,骨科材料概念盘中跳水,截至09点46分,骨科材料概念整体指数下跌1.01%,报1731.140点。从个股上来看,该概念的成分股中,正海生物跌1.24%,奥精医疗、春立医疗、ST凯利跌幅居前。从资金上来看,截止发稿,骨科材料概念主力净流入为-5294.79万,其中康拓医疗受到资金热捧,主力净流入140.14万;拉长时间线来看,该板块近20日主力资金净流入-10.20亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094647a47c0c0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094647a47c0c0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688236","BK0046","01858","BK0251","300653","688613"],"gpt_icon":0},{"id":"2556844583","title":"奥精医疗获融资买入0.11亿元,近三日累计买入0.36亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556844583","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556844583?lang=zh_cn&edition=full","pubTime":"2025-08-02 08:02","pubTimestamp":1754092952,"startTime":"0","endTime":"0","summary":"8月1日,沪深两融数据显示,奥精医疗获融资买入额0.11亿元,居两市第1081位,当日融资偿还额0.12亿元,净卖出127.60万元。最近三个交易日,30日-1日,奥精医疗分别获融资买入0.11亿元、0.14亿元、0.11亿元。融券方面,当日融券卖出0.00万股,净卖出0.00万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802081259972dfd54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802081259972dfd54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2553298919","title":"骨科材料概念盘中拉升,冠昊生物涨2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553298919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553298919?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:44","pubTimestamp":1753235090,"startTime":"0","endTime":"0","summary":"07月23日,骨科材料概念盘中拉升,截至09点44分,骨科材料概念整体指数上涨0.50%,报1595.720点。从个股上来看,该概念的成分股中,冠昊生物涨2.45%,万邦德、西山科技、正海生物涨幅居前。从资金上来看,截止发稿,骨科材料概念主力净流入为-5774.77万,其中奥精医疗受到资金热捧,主力净流入123.33万;拉长时间线来看,该板块近20日主力资金净流入-10.43亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094450954dd443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094450954dd443&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688613","BK0042","BK0086","300238","BK0077","BK0046"],"gpt_icon":0},{"id":"2553694421","title":"奥精医疗(688613.SH):OssaNova™人工骨修复材料在越南获得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2553694421","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553694421?lang=zh_cn&edition=full","pubTime":"2025-07-21 15:43","pubTimestamp":1753083809,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 奥精医疗 发布公告,公司于2024年12月向越南卫生部递交了公司人工骨修复材料的注册申报资料。公司于近日收到越南卫生部通知,公司人工骨修复材料获得批准。本次公司产品在越南获得注册证,是公司海外业务拓展的重要组成部分,将对公司产品在海外的销售起到一定的推动和促进作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"奥精医疗(688613.SH):OssaNova™人工骨修复材料在越南获得注册证","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2553144783","title":"医疗耗材概念盘中拉升,洁特生物涨4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553144783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553144783?lang=zh_cn&edition=full","pubTime":"2025-07-21 09:37","pubTimestamp":1753061865,"startTime":"0","endTime":"0","summary":"07月21日,医疗耗材概念盘中拉升,截至09点37分,医疗耗材概念整体指数上涨0.52%,报1162.260点。从个股上来看,该概念的成分股中,洁特生物涨4.19%,塞力医疗、大博医疗、奥精医疗涨幅居前。从资金上来看,截止发稿,医疗耗材概念概念主力净流入为-230.80万,其中塞力医疗受到资金热捧,主力净流入1296.69万;拉长时间线来看,该板块近20日主力资金净流入-6.63亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721093745954a32d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721093745954a32d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0220","688026","688613","159891"],"gpt_icon":0},{"id":"2551146388","title":"2025年中国口腔种植行业经营效益分析:集采大幅压缩行业利润空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2551146388","media":"前瞻产业研究院","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551146388?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:00","pubTimestamp":1752652815,"startTime":"0","endTime":"0","summary":"2024年我国口腔医院总收入约增长至403亿元。集采政策降低了口腔种植服务价格,这使得口腔医院的盈利空间受到压缩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071616053697a82c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071616053697a82c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0048","600763","BK0284","BK0077","BK0146","06639","BK0114","BK0236","BK0096","688613"],"gpt_icon":0},{"id":"2551163251","title":"渤小海伴您读研报之奥精医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2551163251","media":"渤海证券财富管理","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551163251?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:41","pubTimestamp":1752630109,"startTime":"0","endTime":"0","summary":"骨缺损是指受肿瘤、外伤、坏死、先天畸形等因素影响,导致骨的结构完整性被破坏。奥精医疗矿化胶原微观结构仿生人骨资料来源:公司招股说明书具备三重仿生特征下,公司仿生矿化胶原人工骨材料各项性能比肩自体骨。美国市场方面,Bongold为国内首个获批FDA产品,性能优异。未来随着公司加大海外市场开拓力度,Bongold产品有望恢复增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716095330a6ac4108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716095330a6ac4108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2551662190","title":"多家跨国医疗巨头奔赴链博会,本土药械供应链再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551662190","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551662190?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:15","pubTimestamp":1752596100,"startTime":"0","endTime":"0","summary":"第一财经记者获悉,即将于7月16日开幕的第三届中国国际供应链促进博览会,包括美敦力、阿斯利康、GE医疗等跨国医疗巨头确认参展。美敦力方面介绍,今年是该公司首次参加链博会,并将展示一款全新的由美敦力中国研发中心和本土临床专家合作的起搏心脏导管研发成果。在本届链博会上,阿斯利康国际市场供应链管理高级执行总裁Steven Rota也将发表主旨演讲。阿斯利康已连续第三年参加链博会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600807","600529","688613","688236","688351","688289","BK0239","688075","688314","605369","603301","688161","688607","688253","688067","603987","600055","688108","688050","688271","688212","688217","688193","688298","688301","688198","688606","688626","688139","688767","688026","600587","688393","688338","688013","603976","688426","688468","603387","603658","688151","688410","688677","688581","688755","603205","600645","688317","688656","688399","688617","688358","688389","603222","603014","688114","688580","603880","688068","688575","688366","688576","688016","688273","603309","688029","159891","688085"],"gpt_icon":0},{"id":"2551914530","title":"每周股票复盘:奥精医疗(688613)股东大会审议通过募投项目调整议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2551914530","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551914530?lang=zh_cn&edition=full","pubTime":"2025-07-13 06:25","pubTimestamp":1752359113,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:奥精医疗股东大会审议通过关于部分募投项目调整实施主体、实施地点及部分募投项目子项目调整的议案公司公告汇总奥精医疗2025年第一次临时股东大会于2025年7月11日在北京召开,出席股东和代理人人数89人,持有表决权数量26,135,097股,占公司表决权数量的19.0755%。会议审议通过了关于部分募投项目调整实施主体、实施地点及部分募投项目子项目调整的议案,表决结果为:同意25,800,341股,占98.7191%,反对318,485股,占1.2186%,弃权16,271股,占0.0623%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300001156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2550495779","title":"奥精医疗股价上涨1.78%,临时股东大会通过募投项目调整议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2550495779","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550495779?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:39","pubTimestamp":1752248344,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘,奥精医疗股价报18.31元,较前一交易日上涨1.78%,成交额0.45亿元,换手率1.81%。奥精医疗属于医疗器械行业,专注于高端生物医用材料及再生医学产品的研发、生产和销售。公司主要产品包括人工骨修复材料、口腔修复材料等,应用于骨科、口腔科等领域。消息面上,奥精医疗7月11日晚间公告称,2025年第一次临时股东大会审议通过了《关于部分募投项目调整实施主体、实施地点及部分募投项目子项目调整的议案》。资金方面,7月11日主力资金净流出238.06万元,占流通市值的0.09%。风险提示:市场有风险,投资需谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/11233951645732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2550990605","title":"骨科材料概念盘中拉升,*ST荣控涨1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550990605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550990605?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:48","pubTimestamp":1752198497,"startTime":"0","endTime":"0","summary":"07月11日,骨科材料概念盘中拉升,截至09点48分,骨科材料概念整体指数上涨0.50%,报1514.580点。从个股上来看,该概念的成分股中,*ST荣控涨1.66%,奥精医疗、天智航-U、冠昊生物涨幅居前。从资金上来看,截止发稿,骨科材料概念主力净流入为-1621.00万,其中西山科技受到资金热捧,主力净流入44.78万;拉长时间线来看,该板块近20日主力资金净流入-7.35亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094817a4439bfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094817a4439bfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688277","688576","BK0273","BK0102","688613","BK0020","BK0177","BK0251","000668"],"gpt_icon":0},{"id":"2550698951","title":"骨科材料概念盘中跳水,奥精医疗跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550698951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550698951?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:38","pubTimestamp":1752111521,"startTime":"0","endTime":"0","summary":"07月10日,骨科材料概念盘中跳水,截至09点38分,骨科材料概念整体指数下跌0.54%,报1495.030点。从个股上来看,该概念的成分股中,奥精医疗跌0.45%,金花股份、正海生物、西山科技跌幅居前。从资金上来看,截止发稿,骨科材料概念主力净流入为-242.48万,其中ST凯利受到资金热捧,主力净流入127.68万;拉长时间线来看,该板块近20日主力资金净流入-7.28亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710093841953cd360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710093841953cd360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2549301691","title":"神经外科业务收入大幅下滑被问询,奥精医疗回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2549301691","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549301691?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:54","pubTimestamp":1751860440,"startTime":"0","endTime":"0","summary":"南方财经7月7日电,奥精医疗公告,上海证券交易所于2025年发出《关于奥精医疗科技股份有限公司2024年年度报告的信息披露监管问询函。重点关注神经外科业务收入大幅下滑的问题。公司回应,神经外科业务收入大幅下滑的原因主要包括2024年二季度起多个省市区陆续执行神经外科高值耗材省级联盟集中带量采购,以及骨科人工骨集采在部分地区对神经外科产品的临床使用造成一定不利影响。口腔产品业务收入大幅增长的原因是公司新增优质经销商客户,2024年采购金额4,800余万元,其中口腔科和整形外科产品采购额3,084万元,占齿贝产品总收入的78.44%。(文章来源:南方财经网)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707120516979c92c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707120516979c92c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2549332708","title":"奥精医疗一季度核心产品出货量增长174%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549332708","media":"财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549332708?lang=zh_cn&edition=full","pubTime":"2025-07-06 19:31","pubTimestamp":1751801497,"startTime":"0","endTime":"0","summary":"尽管受2024年集采影响,公司核心产品“骼金”销售价格有所下降,但销量增长较为明显。公告显示,集采的实施使骨科人工骨的临床使用放量明显。奥精医疗的骨科产品“骼金”以330元/cm3的价格中选,在全部人工骨企业中报量按包数排名第一。受需求驱动,奥精医疗“骼金”产品2024全年共销售147.14万cm3,较2023年的76.03万cm3增长93.54%。2025年一季度,良好势头保持延续,“骼金”产品完成销售51.47万cm3,同比增长174%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706193137a439cafb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706193137a439cafb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2549427093","title":"每周股票复盘:奥精医疗(688613)子公司获医疗器械生产许可证及募投项目调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2549427093","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549427093?lang=zh_cn&edition=full","pubTime":"2025-07-06 03:57","pubTimestamp":1751745428,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘,奥精医疗报收于18.27元,较上周的18.21元上涨0.33%。本周,奥精医疗6月30日盘中最高价报19.55元。公司公告汇总奥精医疗科技股份有限公司全资子公司北京奥精医疗器械有限责任公司近日收到北京市药品监督管理局颁发的《医疗器械生产许可证》。此次获得《医疗器械生产许可证》为公司未来产品正式生产及上市销售提供了资质保障。会议主要议案为关于部分募投项目调整实施主体、实施地点及部分募投项目子项目调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","688613","159883","09997","BK1222","09996","BK0251","BK1100"],"gpt_icon":0},{"id":"2548835914","title":"公告解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2548835914","media":"投资快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548835914?lang=zh_cn&edition=full","pubTime":"2025-07-02 07:26","pubTimestamp":1751412368,"startTime":"0","endTime":"0","summary":"国脉科技:预计上半年净利润同比增长60.52%~100.33%国脉科技公告,预计2025年上半年净利润为1.25亿-1.56亿元,比上年同期的7787.31万元增长60.52%~100.33%。总体而言,生产许可证的获得预计将对公司未来业绩产生积极影响。但值得注意的是,2024年公司因集采降价、费用上升等因素导致净利润亏损。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702072814a4c9be6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702072814a4c9be6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0180","BK0077","BK0028","BK0096","BK0145","BK0257","688613","BK0114","601886","BK0039"],"gpt_icon":0},{"id":"2547051450","title":"奥精医疗放量突破创5日新高 估值高压触发资金博弈加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2547051450","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547051450?lang=zh_cn&edition=full","pubTime":"2025-06-30 14:25","pubTimestamp":1751264735,"startTime":"0","endTime":"0","summary":"奥精医疗今日股价大幅上涨,截至14点24分,最新价报19.15元,涨幅达5.16%,盘中创出近5日新高。市场交投活跃,成交金额达5469万元,换手率为2.12%,振幅同步放大至5.16%,呈现放量突破走势。估值压力与资金博弈共振奥精医疗近日股价波动显著,截至6月30日盘中振幅达5.22%,估值分歧成为主要扰动因素。值得注意的是,6月30日主力资金转为净流入133.8万元,显示多空博弈加剧。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630142544a4c5d543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630142544a4c5d543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2547056636","title":"医疗耗材概念盘中拉升,奥精医疗涨3.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547056636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547056636?lang=zh_cn&edition=full","pubTime":"2025-06-30 13:16","pubTimestamp":1751260592,"startTime":"0","endTime":"0","summary":"06月30日,医疗耗材概念盘中拉升,截至13点16分,医疗耗材概念整体指数上涨1.02%,报1064.960点。从个股上来看,该概念的成分股中,奥精医疗涨3.90%,洁特生物、艾隆科技、乐普医疗涨幅居前。从资金上来看,截止发稿,医疗耗材概念概念主力净流入为4923.57万,其中乐普医疗受到资金热捧,主力净流入7924.63万;拉长时间线来看,该板块近20日主力资金净流入-11.23亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630131632a4c5b9ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630131632a4c5b9ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159891","BK0251","688613"],"gpt_icon":0},{"id":"2547049547","title":"每周股票复盘:奥精医疗(688613)调整募投项目及召开临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2547049547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547049547?lang=zh_cn&edition=full","pubTime":"2025-06-29 07:49","pubTimestamp":1751154546,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘,奥精医疗报收于18.21元,较上周的18.24元下跌0.16%。本周,奥精医疗6月25日盘中最高价报18.88元。本周关注点公司公告汇总:奥精医疗将于2025年7月11日召开第一次临时股东大会,审议募投项目调整议案。奥精医疗科技股份有限公司将于2025年7月11日召开2025年第一次临时股东大会,采用现场投票和网络投票相结合的方式。奥精医疗科技股份有限公司调整部分募投项目实施主体、实施地点及部分募投项目子项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900001386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1755217008864,"stockEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.1022},{"period":"3month","weight":0.2451},{"period":"6month","weight":0.1696},{"period":"1year","weight":0.485},{"period":"ytd","weight":0.1236}],"compareEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":0.0461},{"period":"3month","weight":0.0888},{"period":"6month","weight":0.0955},{"period":"1year","weight":0.2862},{"period":"ytd","weight":0.0939}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"奥精医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"7905人(较上一季度减少2.85%)","perCapita":"17331股","listingDate":"2021-05-21","address":"北京市海淀区学院路甲5号1幢1#厂房西区二层015","registeredCapital":"13700万元","survey":" 奥精医疗科技股份有限公司的主营业务是高端生物医用材料及相关医疗器械产品的研发、生产、销售及服务。公司的主要产品是BONGOLD、单牙抗旋基台、骼金、齿贝、颅瑞、口腔种植体。报告期内,公司除获批设立博士后科研工作站,还被列入2024年北京市国际科技创新中心知识产权能力提升计划项目拟支持单位名单。","listedPrice":16.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥精医疗(688613)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥精医疗(688613)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥精医疗,688613,奥精医疗股票,奥精医疗股票老虎,奥精医疗股票老虎国际,奥精医疗行情,奥精医疗股票行情,奥精医疗股价,奥精医疗股市,奥精医疗股票价格,奥精医疗股票交易,奥精医疗股票购买,奥精医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥精医疗(688613)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥精医疗(688613)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}